Is a complete SLXN research report available?

No complete published report is available for Silexion Therapeutics Corp (SLXN) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Silexion Therapeutics Corp (SLXN)

NASDAQ: SLXN · USD

$2.27

-0.11 (-4.6%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first SLXN analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	951.1K
Net income (ttm)	-12.9M
EPS (ttm)	-$63.8
Shares out	419K
Volume	10,732
Beta	-0.26
Price target	$60.0	+2543.2%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -12.9M
EPS (ttm): -$63.8
Market cap: 951.1K

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All SLXN indicators

Market & fundamental data

Available fields

171

Groups with data

Currency

USD

Showing 171 of 171 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0002022416
Company name	Silexion Therapeutics Corp
Country	Israel
Country code	US
Cusip	G1281K148
Employees	14
Employees Change	0%
Employees Change Percent	0
Enterprise value	$527,119
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	KYG1281K1489
Last refreshed	2026-07-25
Market cap	$951,119
Market cap category	Nano-Cap
Price	$2.27
Price currency	USD
Sector	Healthcare
Sector PE	44.8
Sector PE Fwd	23.64
Sic	2836
Symbol	SLXN
Website	https://silexion.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1,357.35%
FCF yield	-1,263.25%
P/B ratio	2.65x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-12.9M
Net Income Growth Years	1%
Profit Per Employee	$-922,143
ROA	-123.3
ROCE	-1,841.7
ROE	-897.5
ROIC	-190.6

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-98.29%
Cagr3y	-94.58%
Cagr5y	-82.29%
EPS Growth Quarters	1
EPS Growth Years	3
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$4.6M
Cash	$2.4M
Current Assets	$4.1M
Current Liabilities	$4.1M
Debt	$2M
Debt Equity	$6.84
Equity	$291,000
Interest Coverage	-4,991
Liabilities	$4.3M
Long Term Assets	$537,000
Long Term Liabilities	$251,000
Net Cash	$424,000
Net Cash By Market Cap	$44.58
Net Debt Equity	$-1.46
Tangible Book Value	$291,000
Tangible Book Value Per Share	$0.86
WACC	0.97

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1
Net Working Capital	$-670,000
Quick ratio	0.59
Working Capital	$5,000

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-98.28%
200-day SMA	16.29
3Y total return	-99.98%
50-day SMA	3.36
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.98%
All Time High	18,302.8
All Time High Change	-99.99%
All Time High Date	2024-08-07
All Time Low	2.2
All Time Low Change	2.99%
All Time Low Date	2026-07-24
ATR	0.3
Beta	-0.26
Beta1y	1.46
Beta2y	0.31
Ch YTD	-88.18
High	2.49
High52	223.6
High52 Date	2025-07-31
High52ch	-98.98%
Low	2.2
Low52	2.2
Low52 Date	2026-07-24
Low52ch	3%
Ma50ch	-32.46%
Price vs 200-day SMA	-86.06%
RSI	32.22
RSI Monthly	9.89
RSI Weekly	19.65
Sharpe ratio	-1.98x
Sortino ratio	-3.01
Tr YTD	-88.18
Tr1m	-16.24%
Tr1w	-12.02%
Tr3m	-75.33%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Ratings	Buy
Earnings EPS Estimate	$-21.2
Operating Income	$-12.7M
Price target	$60
Price Target Change	$2,543

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	414,619%
Float Percent	98.96%
Shares Insiders	0.4%
Shares Institutions	4.53%
Shares Out	418,995
Shares Qo Q	2.67%
Short Float	3.31%
Short Ratio	0.07
Short Shares	3.28

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-12.5M
Average Volume	21,994.55x
Bv Per Share	0.86
CAPEX	$-3,000
Ch1m	-16.24
Ch1w	-12.02
Ch1y	-98.28
Ch3m	-75.33
Ch3y	-99.98
Ch5y	-99.98
Ch6m	-89.54
Change	-4.62%
Change From Open	-5.42
Close	2.38
Days Gap	0.84
Depreciation Amortization	12,000
Dollar Volume	24,361.6
Earnings Date	2026-08-11
Earnings Time	bmo
EBIT	$-10M
EBITDA	$-10M
EPS	$-63.78
F Score	2
FCF	$-12M
FCF EV Yield	-2,279.37x
FCF Per Share	$-28.68
Financing CF	8,291,000
Fiscal Year End	December
Founded	2,008
Income Tax	$3,000
Investing CF	-8,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-15
Last Report Date	2026-03-31
Last Split Date	2026-05-29
Last Split Type	Reverse
Last10k Filing Date	2026-03-17
Ma150	11.43
Ma150ch	-80.13%
Ma20	2.59
Ma20ch	-12.25%
Net CF	-3,735,000
Next Earnings Date	2026-08-11
Open	2.4
Optionable	No
Position In Range	23.08
Post Close	2.27
Postmarket Change Percent	2.64
Postmarket Price	$2.33
Ppne	403,000
Price Date	2026-07-24
Ptbv Ratio	3.27
Relative Volume	0.49x
Share Based Comp	458,000
Tr6m	-89.54%
Volume	10,732

Silexion Therapeutics Corp (SLXN)

Coverage state: Market snapshot only — no published research

Generate the first SLXN analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · SLXN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SLXN indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on SLXN

Frequently asked questions